Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

Anna C. Ferrari; Joshi J. Alumkal; Mark N. Stein; Mary Ellen Taplin; James Babb; Ethan S. Barnett; Alejandro Gomez-Pinillos; Xiaomei Liu; Dirk Moore; Robert DiPaola; Tomasz M. Beer

doi:10.1158/1078-0432.CCR-19-0442

Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

Anna C. Ferrari, Joshi J. Alumkal, Mark N. Stein, Mary Ellen Taplin, James Babb, Ethan S. Barnett, Alejandro Gomez-Pinillos, Xiaomei Liu, Dirk Moore, Robert DiPaola, Tomasz M. Beer

Producción científica: Comment/debate

Resumen

In the original version of this article (1), a sentence was missing in the Results section of the Abstract. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets this error.

Idioma original	English
Páginas (desde-hasta)	2672
Número de páginas	1
Publicación	Clinical Cancer Research
Volumen	25
N.º	8
DOI	https://doi.org/10.1158/1078-0432.CCR-19-0442
Estado	Published - abr 15 2019

Nota bibliográfica

Publisher Copyright:
© 2019 American Association for Cancer Research.

ASJC Scopus subject areas

General Medicine

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1158/1078-0432.CCR-19-0442

Otros archivos y enlaces

Huella

Profundice en los temas de investigación de 'Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)'. En conjunto forman una huella única.

Citar esto

Ferrari, A. C., Alumkal, J. J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R., & Beer, T. M. (2019). Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589). Clinical Cancer Research, 25(8), 2672. https://doi.org/10.1158/1078-0432.CCR-19-0442

@article{250af30b641b4e1aaa4de15c6363e0f3,

title = "Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)",

abstract = "In the original version of this article (1), a sentence was missing in the Results section of the Abstract. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets this error.",

author = "Ferrari, \{Anna C.\} and Alumkal, \{Joshi J.\} and Stein, \{Mark N.\} and Taplin, \{Mary Ellen\} and James Babb and Barnett, \{Ethan S.\} and Alejandro Gomez-Pinillos and Xiaomei Liu and Dirk Moore and Robert DiPaola and Beer, \{Tomasz M.\}",

note = "Publisher Copyright: {\textcopyright} 2019 American Association for Cancer Research.",

year = "2019",

month = apr,

day = "15",

doi = "10.1158/1078-0432.CCR-19-0442",

language = "English",

volume = "25",

pages = "2672",

number = "8",

}

Ferrari, AC, Alumkal, JJ, Stein, MN, Taplin, ME, Babb, J, Barnett, ES, Gomez-Pinillos, A, Liu, X, Moore, D, DiPaola, R & Beer, TM 2019, 'Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)', Clinical Cancer Research, vol. 25, n.º 8, pp. 2672. https://doi.org/10.1158/1078-0432.CCR-19-0442

Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589). / Ferrari, Anna C.; Alumkal, Joshi J.; Stein, Mark N. et al.
En: Clinical Cancer Research, Vol. 25, N.º 8, 15.04.2019, p. 2672.

Producción científica: Comment/debate

TY - JOUR

T1 - Correction

T2 - Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

AU - Ferrari, Anna C.

AU - Alumkal, Joshi J.

AU - Stein, Mark N.

AU - Taplin, Mary Ellen

AU - Babb, James

AU - Barnett, Ethan S.

AU - Gomez-Pinillos, Alejandro

AU - Liu, Xiaomei

AU - Moore, Dirk

AU - DiPaola, Robert

AU - Beer, Tomasz M.

PY - 2019/4/15

Y1 - 2019/4/15

N2 - In the original version of this article (1), a sentence was missing in the Results section of the Abstract. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets this error.

AB - In the original version of this article (1), a sentence was missing in the Results section of the Abstract. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets this error.

UR - https://www.scopus.com/pages/publications/85064926889

UR - https://www.scopus.com/inward/citedby.url?scp=85064926889&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-19-0442

DO - 10.1158/1078-0432.CCR-19-0442

M3 - Comment/debate

C2 - 30988096

AN - SCOPUS:85064926889

SN - 1078-0432

VL - 25

SP - 2672

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 8

ER -